DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

References

Ferreri AJ, Cwynarski K, Pulczynski E. et al.
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

Lancet Haematol 2016;
3: e217-e227

Download Bibliographical Data

Access:
Access: